Teva Shares Rise on Revenue Beat and Innovative Drug Growth Despite Earnings Miss

Teva Pharmaceutical Industries saw its shares climb after reporting revenue that surpassed expectations and growth in innovative drugs, which helped to mitigate an overall earnings miss.